Overview
Parachute runs a platform that connects people with plasma donation opportunities and compensates them for their time and contribution. Donors give plasma at partner donation centers, and the collected plasma is used to manufacture medicines that treat chronic illnesses such as immune disorders, liver disease, bleeding disorders, and cancer. The way it works is by recruiting donors, coordinating appointments, and providing payment for donations, helping facilities maintain a steady supply of plasma for therapies. Parachute differentiates itself by focusing on expanding the donor base and shortening the gap between donation and medicine production, aiming to reduce shortages and improve patient access. The company’s goal is to increase the availability of plasma-derived treatments by encouraging more people to donate and by ensuring a reliable flow of plasma to treatment manufacturers.
Work here?Claim your company
Simplify's take
What believers are saying
- A November 2026 recruiter posting targets 60+ centers, showing aggressive expansion momentum.
- Company pages updated October 2026 say Parachute is still hiring and opening new roles.
- Parachute says it adopted Terumo's Rika system to speed collections and improve donor experience.
What critics are saying
- Clark v. Join Parachute, LLC was filed July 20, 2026, signaling employment-discrimination exposure.
- Rapid center expansion to 60+ sites this year strains recruiting, training, and quality control.
- Plasma supply businesses face existential FDA, staffing, or donor-compliance shocks that can shut centers.
What makes Join Parachute unique
- Join Parachute pairs donor app scheduling with hospitality-style plasma centers across 30+ locations.
- Its prepaid Visa payout card and transparent pay model reduce friction for repeat donors.
- Management says Parachute grew from 2 to 50+ operations in about three years.
Help us improve and share your feedback! Did you find this helpful?